世界のエフリンB型受容体4市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV05750)
◆英語タイトル:Global Ephrin Type B Receptor 4 Market Insights and Forecast to 2026
◆商品コード:QYR20NV05750
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:119
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはエフリンB型受容体4の世界市場について調査・分析した資料です。種類別(VDAU-11、Vas-01、トシレートテセバチニブ、その他)の市場規模、用途別(固形腫瘍、胆管がん、結腸直腸がん、黒色腫、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別エフリンB型受容体4の競争状況、市場シェア
・世界のエフリンB型受容体4市場:種類別市場規模 2015年-2020年(VDAU-11、Vas-01、トシレートテセバチニブ、その他)
・世界のエフリンB型受容体4市場:種類別市場規模予測 2021年-2026年(VDAU-11、Vas-01、トシレートテセバチニブ、その他)
・世界のエフリンB型受容体4市場:用途別市場規模 2015年-2020年(固形腫瘍、胆管がん、結腸直腸がん、黒色腫、その他)
・世界のエフリンB型受容体4市場:用途別市場規模予測 2021年-2026年(固形腫瘍、胆管がん、結腸直腸がん、黒色腫、その他)
・北米のエフリンB型受容体4市場分析:米国、カナダ
・ヨーロッパのエフリンB型受容体4市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのエフリンB型受容体4市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のエフリンB型受容体4市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのエフリンB型受容体4市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Eisai Co Ltd、Kadmon Corp LLC、VasGene Therapeutics Inc
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Ephrin Type B Receptor 4 Market
The global Ephrin Type B Receptor 4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Ephrin Type B Receptor 4 Scope and Market Size
Ephrin Type B Receptor 4 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ephrin Type B Receptor 4 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Ephrin Type B Receptor 4 market is segmented into
VDAU-11
Vas-01
Tesevatinib Tosylate
Others

Segment by Application, the Ephrin Type B Receptor 4 market is segmented into
Solid Tumor
Bile Duct Cancer
Colorectal Cancer
Melanoma
Others

Regional and Country-level Analysis
The Ephrin Type B Receptor 4 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ephrin Type B Receptor 4 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ephrin Type B Receptor 4 Market Share Analysis
Ephrin Type B Receptor 4 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ephrin Type B Receptor 4 business, the date to enter into the Ephrin Type B Receptor 4 market, Ephrin Type B Receptor 4 product introduction, recent developments, etc.

The major vendors covered:
Eisai Co Ltd
Kadmon Corp LLC
VasGene Therapeutics Inc

【レポートの目次】

1 Study Coverage
1.1 Ephrin Type B Receptor 4 Product Introduction
1.2 Market Segments
1.3 Key Ephrin Type B Receptor 4 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Ephrin Type B Receptor 4 Market Size Growth Rate by Type
1.4.2 VDAU-11
1.4.3 Vas-01
1.4.4 Tesevatinib Tosylate
1.4.5 Others
1.5 Market by Application
1.5.1 Global Ephrin Type B Receptor 4 Market Size Growth Rate by Application
1.5.2 Solid Tumor
1.5.3 Bile Duct Cancer
1.5.4 Colorectal Cancer
1.5.5 Melanoma
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Ephrin Type B Receptor 4 Market Size, Estimates and Forecasts
2.1.1 Global Ephrin Type B Receptor 4 Revenue 2015-2026
2.1.2 Global Ephrin Type B Receptor 4 Sales 2015-2026
2.2 Global Ephrin Type B Receptor 4, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Ephrin Type B Receptor 4 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Ephrin Type B Receptor 4 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Ephrin Type B Receptor 4 Competitor Landscape by Players
3.1 Ephrin Type B Receptor 4 Sales by Manufacturers
3.1.1 Ephrin Type B Receptor 4 Sales by Manufacturers (2015-2020)
3.1.2 Ephrin Type B Receptor 4 Sales Market Share by Manufacturers (2015-2020)
3.2 Ephrin Type B Receptor 4 Revenue by Manufacturers
3.2.1 Ephrin Type B Receptor 4 Revenue by Manufacturers (2015-2020)
3.2.2 Ephrin Type B Receptor 4 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ephrin Type B Receptor 4 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Ephrin Type B Receptor 4 Revenue in 2019
3.2.5 Global Ephrin Type B Receptor 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Ephrin Type B Receptor 4 Price by Manufacturers
3.4 Ephrin Type B Receptor 4 Manufacturing Base Distribution, Product Types
3.4.1 Ephrin Type B Receptor 4 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ephrin Type B Receptor 4 Product Type
3.4.3 Date of International Manufacturers Enter into Ephrin Type B Receptor 4 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Ephrin Type B Receptor 4 Market Size by Type (2015-2020)
4.1.1 Global Ephrin Type B Receptor 4 Sales by Type (2015-2020)
4.1.2 Global Ephrin Type B Receptor 4 Revenue by Type (2015-2020)
4.1.3 Ephrin Type B Receptor 4 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Ephrin Type B Receptor 4 Market Size Forecast by Type (2021-2026)
4.2.1 Global Ephrin Type B Receptor 4 Sales Forecast by Type (2021-2026)
4.2.2 Global Ephrin Type B Receptor 4 Revenue Forecast by Type (2021-2026)
4.2.3 Ephrin Type B Receptor 4 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Ephrin Type B Receptor 4 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Ephrin Type B Receptor 4 Market Size by Application (2015-2020)
5.1.1 Global Ephrin Type B Receptor 4 Sales by Application (2015-2020)
5.1.2 Global Ephrin Type B Receptor 4 Revenue by Application (2015-2020)
5.1.3 Ephrin Type B Receptor 4 Price by Application (2015-2020)
5.2 Ephrin Type B Receptor 4 Market Size Forecast by Application (2021-2026)
5.2.1 Global Ephrin Type B Receptor 4 Sales Forecast by Application (2021-2026)
5.2.2 Global Ephrin Type B Receptor 4 Revenue Forecast by Application (2021-2026)
5.2.3 Global Ephrin Type B Receptor 4 Price Forecast by Application (2021-2026)

6 North America
6.1 North America Ephrin Type B Receptor 4 by Country
6.1.1 North America Ephrin Type B Receptor 4 Sales by Country
6.1.2 North America Ephrin Type B Receptor 4 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Ephrin Type B Receptor 4 Market Facts & Figures by Type
6.3 North America Ephrin Type B Receptor 4 Market Facts & Figures by Application

7 Europe
7.1 Europe Ephrin Type B Receptor 4 by Country
7.1.1 Europe Ephrin Type B Receptor 4 Sales by Country
7.1.2 Europe Ephrin Type B Receptor 4 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ephrin Type B Receptor 4 Market Facts & Figures by Type
7.3 Europe Ephrin Type B Receptor 4 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Ephrin Type B Receptor 4 by Region
8.1.1 Asia Pacific Ephrin Type B Receptor 4 Sales by Region
8.1.2 Asia Pacific Ephrin Type B Receptor 4 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Ephrin Type B Receptor 4 Market Facts & Figures by Type
8.3 Asia Pacific Ephrin Type B Receptor 4 Market Facts & Figures by Application

9 Latin America
9.1 Latin America Ephrin Type B Receptor 4 by Country
9.1.1 Latin America Ephrin Type B Receptor 4 Sales by Country
9.1.2 Latin America Ephrin Type B Receptor 4 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Ephrin Type B Receptor 4 Market Facts & Figures by Type
9.3 Central & South America Ephrin Type B Receptor 4 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Ephrin Type B Receptor 4 by Country
10.1.1 Middle East and Africa Ephrin Type B Receptor 4 Sales by Country
10.1.2 Middle East and Africa Ephrin Type B Receptor 4 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Ephrin Type B Receptor 4 Market Facts & Figures by Type
10.3 Middle East and Africa Ephrin Type B Receptor 4 Market Facts & Figures by Application

11 Company Profiles
11.1 Eisai Co Ltd
11.1.1 Eisai Co Ltd Corporation Information
11.1.2 Eisai Co Ltd Description and Business Overview
11.1.3 Eisai Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eisai Co Ltd Ephrin Type B Receptor 4 Products Offered
11.1.5 Eisai Co Ltd Related Developments
11.2 Kadmon Corp LLC
11.2.1 Kadmon Corp LLC Corporation Information
11.2.2 Kadmon Corp LLC Description and Business Overview
11.2.3 Kadmon Corp LLC Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Kadmon Corp LLC Ephrin Type B Receptor 4 Products Offered
11.2.5 Kadmon Corp LLC Related Developments
11.3 VasGene Therapeutics Inc
11.3.1 VasGene Therapeutics Inc Corporation Information
11.3.2 VasGene Therapeutics Inc Description and Business Overview
11.3.3 VasGene Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 VasGene Therapeutics Inc Ephrin Type B Receptor 4 Products Offered
11.3.5 VasGene Therapeutics Inc Related Developments
11.1 Eisai Co Ltd
11.1.1 Eisai Co Ltd Corporation Information
11.1.2 Eisai Co Ltd Description and Business Overview
11.1.3 Eisai Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eisai Co Ltd Ephrin Type B Receptor 4 Products Offered
11.1.5 Eisai Co Ltd Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Ephrin Type B Receptor 4 Market Estimates and Projections by Region
12.1.1 Global Ephrin Type B Receptor 4 Sales Forecast by Regions 2021-2026
12.1.2 Global Ephrin Type B Receptor 4 Revenue Forecast by Regions 2021-2026
12.2 North America Ephrin Type B Receptor 4 Market Size Forecast (2021-2026)
12.2.1 North America: Ephrin Type B Receptor 4 Sales Forecast (2021-2026)
12.2.2 North America: Ephrin Type B Receptor 4 Revenue Forecast (2021-2026)
12.2.3 North America: Ephrin Type B Receptor 4 Market Size Forecast by Country (2021-2026)
12.3 Europe Ephrin Type B Receptor 4 Market Size Forecast (2021-2026)
12.3.1 Europe: Ephrin Type B Receptor 4 Sales Forecast (2021-2026)
12.3.2 Europe: Ephrin Type B Receptor 4 Revenue Forecast (2021-2026)
12.3.3 Europe: Ephrin Type B Receptor 4 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Ephrin Type B Receptor 4 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Ephrin Type B Receptor 4 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Ephrin Type B Receptor 4 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Ephrin Type B Receptor 4 Market Size Forecast by Region (2021-2026)
12.5 Latin America Ephrin Type B Receptor 4 Market Size Forecast (2021-2026)
12.5.1 Latin America: Ephrin Type B Receptor 4 Sales Forecast (2021-2026)
12.5.2 Latin America: Ephrin Type B Receptor 4 Revenue Forecast (2021-2026)
12.5.3 Latin America: Ephrin Type B Receptor 4 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Ephrin Type B Receptor 4 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Ephrin Type B Receptor 4 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Ephrin Type B Receptor 4 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Ephrin Type B Receptor 4 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Ephrin Type B Receptor 4 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Ephrin Type B Receptor 4 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Eisai Co Ltd、Kadmon Corp LLC、VasGene Therapeutics Inc

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のエフリンB型受容体4市場2026:インサイト・予測(Global Ephrin Type B Receptor 4 Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。